CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleMarket cap is $1.39B, above the global median of $1.18B
- FinancialsAltman Z-Score 2.02: grey zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.39BUSDvs all stocks (USD)
Revenue (TTM)
421.75MUSDvs all stocks (USD)
Profit Margin
-16.22%Beta
1.41xvs all stocks
52-Week Change
-25.21%vs all stocks
Market Capitalization
1.39BUSDvs all stocks (USD)
Enterprise Value
1.51BUSDvs all stocks (USD)
Forward P/E
23.31xPrice to Sales (TTM)
3.29xPrice to Book (MRQ)
1.44xEnterprise to Revenue
3.57xEnterprise to EBITDA
15.99xGross Margin
62.34%Profit Margin
-16.22%Operating Margin
-0.21%Return on Assets (TTM)
0.77%Return on Equity (TTM)
-2.21%Revenue (TTM)
421.75MUSDvs all stocks (USD)
Revenue per Share (TTM)
2.67USDUpdated Sep 27, 2026Quarterly Revenue Growth
1.00%Gross Profit (TTM)
259.83MUSDvs all stocks (USD)
EBITDA (TTM)
78.78MUSDvs all stocks (USD)
Net Income (TTM)
-22.50MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-10.81%Operating Cash Flow (TTM)
82.86MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
62.58MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
418.84MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
161.13MUSDFY2025 · Dec 31, 2025Gross Profit
257.71MUSDFY2025 · Dec 31, 2025Operating Income
21.02MUSDvs all stocks (USD)
Pre-tax Income
7.62MUSDFY2025 · Dec 31, 2025Income Tax Expense
9.21MUSDFY2025 · Dec 31, 2025Net Income
-1.59MUSDFY2025 · Dec 31, 2025EBIT
27.35MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
102.52MUSDFY2025 · Dec 31, 2025Research & Development
41.04MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
139.10MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
19.74MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.0100USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.0100USDFY2025 · Dec 31, 2025Basic Shares Outstanding
160.39MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
160.39MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-1.59MUSDFY2025 · Dec 31, 2025Operating Cash Flow
91.68MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
189.39MUSDFY2025 · Dec 31, 2025Income Tax Paid
12.22MUSDFY2025 · Dec 31, 2025Interest Paid
19.13MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-1.59MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
75.16MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-8.32MUSDFY2025 · Dec 31, 2025Stock-based Compensation
33.08MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-4.05MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
428.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.02MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
0.00USDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Net Investing Cash Flow
0.00USDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-2.99MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-42.61MUSDFY2025 · Dec 31, 2025Other Financing Charges
-18.39MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-63.99MUSDFY2025 · Dec 31, 2025Shares Outstanding
152.50MSharesUpdated Sep 27, 2026Float Shares
111.95MSharesUpdated Sep 27, 2026Shares Short
28.81MSharesUpdated Sep 27, 2026Short Ratio
13.79daysvs all stocks
Short % of Shares Outstanding
29.59%vs all stocks
% Held by Insiders
2.73%vs all stocks
% Held by Institutions
112.93%vs all stocks
Total Cash (MRQ)
184.87MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.21USDUpdated Sep 27, 2026Total Debt (MRQ)
301.94MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.3124xCurrent Ratio (MRQ)
2.55xBook Value per Share (MRQ)
6.34USDUpdated Sep 27, 2026Total Assets
1.56BUSDvs all stocks (USD)
Total Current Assets
315.12MUSDFY2025 · Dec 31, 2025Total Liabilities
493.79MUSDFY2025 · Dec 31, 2025Total Non-current Assets
1.24BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
340.40MUSDFY2025 · Dec 31, 2025Total Current Liabilities
153.38MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
189.39MUSDFY2025 · Dec 31, 2025Accounts Receivable
94.56MUSDFY2025 · Dec 31, 2025Accounts Payable
3.43MUSDFY2025 · Dec 31, 2025Short-term Debt
7.42MUSDFY2025 · Dec 31, 2025Deferred Revenue
75.41MUSDFY2025 · Dec 31, 2025Other Current Liabilities
23.07MUSDFY2025 · Dec 31, 2025Long-term Debt
298.57MUSDFY2025 · Dec 31, 2025Common Stock (Book)
1.64MUSDFY2025 · Dec 31, 2025Retained Earnings
-129.88MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.06BUSDvs all stocks (USD)
Treasury Stock
66.66MUSDFY2025 · Dec 31, 202552-Week Low
4.45USDUpdated Sep 27, 202652-Week High
13.88USDUpdated Sep 27, 202652-Week Change
-25.21%vs all stocks
Beta
1.41xvs all stocks
50-Day MA
8.00USDUpdated Sep 27, 2026200-Day MA
7.18USDUpdated Sep 27, 2026Avg 10-Day Volume
2.87MSharesUpdated Sep 27, 2026Avg 30-Day Volume
2.34MSharesUpdated Sep 27, 2026Diluted EPS (TTM)
-0.1400USDUpdated Sep 27, 2026Other Income / Expense
6.34MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Depreciation-Heavy Reported Profit
It reports a profit, and much of the gap to cash is depreciation rather than earnings.
Reads
Diagnostic
Earnings Growth With Heavy Accrual Component
It reports a profit, with depreciation heavy in the cash bridge and receivables rising.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.62Profit Margin: -0.16
Prioritizing buybacks over growth reinvestmentNotable
Buyback Intensity: 0.03Revenue Growth YoY: 0.01
Financial Health
Altman Z-Score 2.02: grey zoneSignificant
Altman Z-Score: 2.02
High earnings qualityNotable
Earnings Quality Score: 1.78
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Market cap is $1.39B, above the global median of $1.18BNotable
Market cap (USD): 1,389,628,285Global Median: 1,180,223,658.953
Levered free cash flow is $62.58M, above the global median of $18.73MNotable
Levered free cash flow (USD): 62,582,376Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Richinfo Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowProduction
Shenzhen Urban Transport Planning Center Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InRuleInterface
Red Violet Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InRiskRule
Indegene Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowInterface
Cloudwalk Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InRuleProduction
Trs Information Technology Co.
Tier 1SenseMakingRecurring-Revenue Lock-InProductionFlow
Amplitude, Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InInterfaceFlow
NSD Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowProduction
ZoomInfo Technologies Inc.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowInterface
Hangzhou Raycloud Technology Co., Ltd.
Tier 1SenseMakingRecurring-Revenue Lock-InFlowProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Grid Dynamics Holdings, Inc.
3 interpretationsDepreciation-Heavy Reported ProfitEarnings Growth With Heavy Accrual ComponentRevenue Growing With Receivables Growing
Gyre Therapeutics Inc.
2 interpretationsDepreciation-Heavy Reported ProfitEarnings Growth With Heavy Accrual Component
Travere Therapeutics Inc.
3 interpretationsDepreciation-Heavy Reported ProfitEarnings Growth With Heavy Accrual ComponentRevenue Growing With Receivables Growing